Provided by Tiger Trade Technology Pte. Ltd.

4D Molecular Therapeutics

14.11
-0.5600-3.82%
Post-market: 13.80-0.3100-2.20%17:56 EDT
Volume:1.40M
Turnover:19.69M
Market Cap:779.50M
PE:-5.12
High:14.60
Open:14.49
Low:13.67
Close:14.67
52wk High:16.93
52wk Low:5.97
Shares:55.24M
Float Shares:42.02M
Volume Ratio:1.42
T/O Rate:3.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7580
EPS(LYR):-2.4200
ROE:-43.25%
ROA:-25.09%
PB:1.91
PE(LYR):-5.83

Loading ...

Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Aug 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 20, 2026

Major Issues Report

Form 8-K - Current report
Jul 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 12, 2026

Correspondence

Form CORRESP - Correspondence